TIMOLOL MALEATE OPHTHALMIC

TIMOLOL MALEATE OPHTHALMIC was reported 7679 times

TIMOLOL MALEATE OPHTHALMIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL END PLATE INFLAMMATION 8 0.4000
1 TRABECULECTOMY 9 0.0978
2 DEVELOPMENTAL GLAUCOMA 5 0.0769
3 CORNEAL DEPOSITS 38 0.0511
4 EOSINOPHILIC CELLULITIS 9 0.0423
5 FLAT ANTERIOR CHAMBER OF EYE 7 0.0391
6 INTRAOCULAR PRESSURE FLUCTUATION 7 0.0355
7 ANTERIOR CHAMBER DISORDER 8 0.0348
8 CONJUNCTIVAL EROSION 4 0.0331
9 OPTIC NERVE CUPPING 4 0.0315
10 GLAUCOMA SURGERY 8 0.0312
11 HYPOTONY OF EYE 11 0.0262
12 CHOROIDAL DETACHMENT 13 0.0234
13 HYPHAEMA 12 0.0230
14 EYELID PAIN 43 0.0211
15 ECTROPION 7 0.0208
16 CHORIORETINAL DISORDER 4 0.0203
17 INTRAOCULAR PRESSURE TEST ABNORMAL 14 0.0199
18 MILIA 7 0.0193
19 IRIS HYPERPIGMENTATION 4 0.0192
20 PERIORBITAL PAIN 15 0.0177
21 GROWTH OF EYELASHES 14 0.0177
22 IRIS ADHESIONS 9 0.0175
23 INTRAOCULAR PRESSURE INCREASED 223 0.0174
24 REACTION TO PRESERVATIVES 14 0.0172
25 CORNEAL DEGENERATION 4 0.0165
26 CHOROIDAL EFFUSION 13 0.0162
27 EYE REDNESS 4 0.0143
28 DRUG-GENETIC INTERACTION 5 0.0140
29 INTRAOCULAR PRESSURE DECREASED 7 0.0133
30 PRODUCT DROPPER ISSUE 10 0.0127
31 INTRAOCULAR LENS IMPLANT 6 0.0121
32 TREATMENT FAILURE 979 0.0118
33 EYE SYMPTOM 4 0.0112
34 OBSTRUCTIVE UROPATHY 4 0.0099
35 FOREIGN BODY SENSATION IN EYES 61 0.0096
36 EYELID IRRITATION 23 0.0092
37 CORNEAL TRANSPLANT 7 0.0089
38 CORNEAL EPITHELIUM DEFECT 5 0.0086
39 EYE BURNS 5 0.0085
40 GENITAL ERYTHEMA 4 0.0081
41 GLAUCOMA 154 0.0080
42 CORNEAL SCAR 4 0.0080
43 SICK SINUS SYNDROME 9 0.0078
44 GLARE 4 0.0078
45 EYE PAIN 436 0.0077
46 IRIS DISORDER 4 0.0074
47 SUPERFICIAL INJURY OF EYE 8 0.0073
48 CONJUNCTIVAL HYPERAEMIA 26 0.0073
49 CORNEAL OEDEMA 16 0.0071
50 INSTILLATION SITE IRRITATION 8 0.0068
51 RETINAL VASCULAR OCCLUSION 5 0.0068
52 EYELIDS PRURITUS 21 0.0067
53 CHROMATOPSIA 5 0.0066
54 PRODUCT CONTAINER ISSUE 56 0.0065
55 OPEN ANGLE GLAUCOMA 4 0.0065
56 ERYTHEMA OF EYELID 35 0.0065
57 TOXIC ANTERIOR SEGMENT SYNDROME 7 0.0064
58 CORNEAL DISORDER 14 0.0064
59 EYELID EXFOLIATION 5 0.0063
60 FOREIGN BODY IN EYE 6 0.0063
61 EYELID MARGIN CRUSTING 18 0.0062
62 CONJUNCTIVITIS ALLERGIC 9 0.0061
63 GINGIVAL DISCOMFORT 4 0.0061
64 ABNORMAL SENSATION IN EYE 26 0.0060
65 EYE IRRITATION 346 0.0060
66 OCULAR DISCOMFORT 67 0.0060
67 CONJUNCTIVAL OEDEMA 6 0.0058
68 OCULAR HYPERTENSION 11 0.0057
69 EYELID DISORDER 13 0.0056
70 SWELLING OF EYELID 33 0.0053
71 OPTIC NERVE INJURY 6 0.0052
72 EYE PRURITUS 169 0.0050
73 EYE INFLAMMATION 47 0.0049
74 BRADYARRHYTHMIA 8 0.0049
75 VITAMIN B12 DECREASED 14 0.0049
76 OCULAR HYPERAEMIA 224 0.0047
77 ANGLE CLOSURE GLAUCOMA 12 0.0047
78 EYE DISCHARGE 48 0.0046
79 PRODUCT DEPOSIT 7 0.0045
80 PRODUCT DELIVERY MECHANISM ISSUE 24 0.0045
81 VITREOUS HAEMORRHAGE 12 0.0043
82 PHOTOPHOBIA 81 0.0043
83 LACRIMATION INCREASED 129 0.0043
84 JOINT NOISE 8 0.0041
85 BLEPHARITIS 16 0.0040
86 EYE COLOUR CHANGE 4 0.0039
87 EYE ALLERGY 6 0.0039
88 IRIDOCYCLITIS 12 0.0038
89 PLASMACYTOMA 7 0.0038
90 INCORRECT DOSE ADMINISTERED BY PRODUCT 6 0.0037
91 EYE INFECTION 42 0.0037
92 ULCERATIVE KERATITIS 10 0.0036
93 INSTILLATION SITE PAIN 9 0.0036
94 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
95 NODAL RHYTHM 5 0.0034
96 PERIORBITAL SWELLING 19 0.0034
97 ASTHENOPIA 18 0.0033
98 BLADDER PROLAPSE 4 0.0033
99 ORAL MUCOSA EROSION 4 0.0033
100 NEURITIS 5 0.0032
101 SINUS ARREST 5 0.0032
102 MICROCEPHALY 4 0.0031
103 CALCIUM DEFICIENCY 4 0.0031
104 READING DISORDER 7 0.0031
105 CORNEAL OPACITY 4 0.0029
106 CORNEAL ABRASION 4 0.0029
107 TREATMENT DELAYED 5 0.0029
108 PUPILLARY REFLEX IMPAIRED 5 0.0027
109 CATARACT OPERATION 16 0.0027
110 RETINAL DISORDER 7 0.0027
111 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
112 HORDEOLUM 11 0.0025
113 KERATOPATHY 4 0.0025
114 MYOPIA 6 0.0025
115 RECALLED PRODUCT ADMINISTERED 24 0.0025
116 HAND DEFORMITY 33 0.0025
117 ENDOPHTHALMITIS 15 0.0025
118 VISUAL ACUITY REDUCED 83 0.0025
119 SCIATICA 39 0.0024
120 RETINAL VEIN OCCLUSION 7 0.0024
121 PERSECUTORY DELUSION 6 0.0024
122 EYE OPERATION 11 0.0024
123 DEAFNESS UNILATERAL 13 0.0024
124 PRODUCT DISPENSING ISSUE 10 0.0023
125 ATRIOVENTRICULAR BLOCK 18 0.0023
126 DRY EYE 115 0.0023
127 PRODUCT USE COMPLAINT 36 0.0023
128 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
129 BLINDNESS UNILATERAL 31 0.0022
130 BLOOD PHOSPHORUS INCREASED 6 0.0022
131 ESSENTIAL HYPERTENSION 4 0.0022
132 SINUS BRADYCARDIA 21 0.0022
133 LOBAR PNEUMONIA 4 0.0022
134 EYE SWELLING 80 0.0021
135 PULSE ABNORMAL 5 0.0021
136 EYE OEDEMA 5 0.0020
137 EYE INJURY 6 0.0020
138 MACULOPATHY 7 0.0020
139 ENDODONTIC PROCEDURE 5 0.0020
140 PRODUCT CONTAMINATION 7 0.0020
141 BLINDNESS 79 0.0019
142 MICROCYTIC ANAEMIA 4 0.0019
143 EYE DISORDER 63 0.0019
144 BLINDNESS TRANSIENT 14 0.0019
145 RADICULOPATHY 5 0.0019
146 NON-CARDIAC CHEST PAIN 6 0.0019
147 BUNDLE BRANCH BLOCK LEFT 8 0.0019
148 ANGIONEUROTIC OEDEMA 5 0.0019
149 VISION BLURRED 256 0.0019
150 CALCINOSIS 4 0.0018
151 CATARACT 103 0.0017
152 MULTIPLE MYELOMA 8 0.0017
153 LUMBAR SPINAL STENOSIS 5 0.0017
154 PRODUCT ADMINISTRATION ERROR 33 0.0016
155 TENSION HEADACHE 7 0.0016
156 INFUSION SITE PRURITUS 5 0.0016
157 EXTRASYSTOLES 11 0.0016
158 EYELID PTOSIS 16 0.0016
159 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
160 VISUAL DISTURBANCE 9 0.0016
161 EYELID OEDEMA 18 0.0015
162 LIPOMA 4 0.0015
163 ACTINIC KERATOSIS 4 0.0015
164 VITREOUS FLOATERS 15 0.0015
165 RETINAL DETACHMENT 14 0.0015
166 DEAFNESS NEUROSENSORY 5 0.0015
167 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
168 HEART RATE DECREASED 53 0.0015
169 MACULAR DEGENERATION 18 0.0015
170 CEREBRAL ATROPHY 6 0.0015
171 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
172 EYE HAEMORRHAGE 20 0.0015
173 BODY HEIGHT DECREASED 16 0.0015
174 ANAESTHETIC COMPLICATION 4 0.0015
175 SPINAL COLUMN STENOSIS 7 0.0015
176 VITAMIN B12 DEFICIENCY 6 0.0015
177 UVEITIS 20 0.0015
178 HEPATIC CYST 5 0.0015
179 BRADYCARDIA 77 0.0015
180 ACCIDENTAL EXPOSURE 6 0.0014
181 AORTIC VALVE INCOMPETENCE 6 0.0014
182 ABSCESS LIMB 6 0.0014
183 VISUAL IMPAIRMENT 174 0.0014
184 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
185 CONJUNCTIVITIS 26 0.0014
186 DEFORMITY 13 0.0014
187 VISUAL FIELD DEFECT 10 0.0014
188 INCREASED UPPER AIRWAY SECRETION 7 0.0014
189 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
190 RETINOPATHY 5 0.0013
191 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
192 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
193 FACE INJURY 5 0.0013
194 EYE MOVEMENT DISORDER 9 0.0013
195 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
196 INFUSION SITE ERYTHEMA 11 0.0013
197 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
198 DIASTOLIC DYSFUNCTION 4 0.0013
199 NASAL DRYNESS 8 0.0013
200 PHOTOPSIA 8 0.0013
201 NASAL DISCOMFORT 10 0.0013
202 BLADDER PAIN 4 0.0013
203 FAECAL INCONTINENCE 6 0.0012
204 PRODUCT LEAKAGE 7 0.0012
205 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
206 MADAROSIS 14 0.0012
207 PROCEDURAL COMPLICATION 9 0.0012
208 POOR PERIPHERAL CIRCULATION 5 0.0012
209 RENAL FAILURE CHRONIC 9 0.0012
210 BRONCHOPNEUMONIA 4 0.0012
211 PERIPHERAL COLDNESS 16 0.0012
212 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
213 FAILURE TO THRIVE 6 0.0012
214 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
215 ORTHOSTATIC HYPOTENSION 20 0.0011
216 CAROTID ARTERY STENOSIS 4 0.0011
217 EMBOLIC STROKE 4 0.0011
218 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
219 RHINITIS 9 0.0011
220 INFUSION SITE SWELLING 7 0.0011
221 HYPOTONIA 11 0.0011
222 FULL BLOOD COUNT DECREASED 22 0.0011
223 ANOREXIA 14 0.0011
224 PSYCHIATRIC SYMPTOM 8 0.0011
225 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
226 HYPERKALAEMIA 38 0.0011
227 DRY THROAT 11 0.0011
228 NOCTURIA 13 0.0011
229 MACULAR OEDEMA 6 0.0011
230 YELLOW SKIN 5 0.0011
231 SPINAL DISORDER 10 0.0011
232 COLITIS MICROSCOPIC 5 0.0011
233 PRODUCT PACKAGING ISSUE 10 0.0011
234 SUBCUTANEOUS ABSCESS 5 0.0010
235 ATELECTASIS 10 0.0010
236 HYPOALBUMINAEMIA 8 0.0010
237 FAECES HARD 4 0.0010
238 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
239 SINUS HEADACHE 6 0.0010
240 ATRIAL FLUTTER 8 0.0010
241 OBSTRUCTION 4 0.0010
242 CORONARY ARTERY STENOSIS 5 0.0010
243 DUODENAL ULCER 7 0.0010
244 EMPHYSEMA 10 0.0010
245 FOETAL GROWTH RESTRICTION 6 0.0010
246 DIVERTICULUM 7 0.0010
247 CARDIOMEGALY 12 0.0010
248 EAR DISCOMFORT 10 0.0010
249 CEREBRAL ISCHAEMIA 5 0.0010
250 HYPERSENSITIVITY 180 0.0010
251 DIPLOPIA 25 0.0010
252 PRE-EXISTING CONDITION IMPROVED 6 0.0010
253 ARTERIOSCLEROSIS 9 0.0010
254 PHARYNGOLARYNGEAL PAIN 5 0.0009
255 POST PROCEDURAL COMPLICATION 18 0.0009
256 TINNITUS 43 0.0009
257 FOOD POISONING 5 0.0009
258 PAROSMIA 7 0.0009
259 CHEILITIS 5 0.0009
260 ANGINA UNSTABLE 6 0.0009
261 SEASONAL ALLERGY 13 0.0009
262 NONSPECIFIC REACTION 5 0.0009
263 RED BLOOD CELL COUNT DECREASED 26 0.0009
264 HYPERKERATOSIS 5 0.0009
265 GINGIVAL SWELLING 4 0.0009
266 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
267 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
268 BLOOD SODIUM DECREASED 17 0.0009
269 HALLUCINATION, VISUAL 19 0.0009
270 DRY MOUTH 73 0.0009
271 BLOOD UREA INCREASED 15 0.0009
272 DRUG TOXICITY 12 0.0009
273 MYOCARDIAL ISCHAEMIA 10 0.0009
274 EAR PAIN 17 0.0009
275 EAR DISORDER 4 0.0009
276 MIOSIS 7 0.0009
277 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
278 SKIN ATROPHY 5 0.0009
279 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
280 NEPHROGENIC ANAEMIA 4 0.0009
281 DERMATITIS 18 0.0009
282 DYSPHONIA 50 0.0009
283 RHINORRHOEA 55 0.0009
284 SPINAL COMPRESSION FRACTURE 7 0.0008
285 RETINAL HAEMORRHAGE 6 0.0008
286 ISCHAEMIC STROKE 15 0.0008
287 ODYNOPHAGIA 5 0.0008
288 SKIN LACERATION 9 0.0008
289 DIZZINESS POSTURAL 8 0.0008
290 PRESYNCOPE 20 0.0008
291 VERTIGO 50 0.0008
292 SKIN HYPERPIGMENTATION 7 0.0008
293 EXPIRED DRUG ADMINISTERED 4 0.0008
294 DIABETIC NEUROPATHY 4 0.0008
295 HAEMATOCRIT DECREASED 16 0.0008
296 GINGIVAL BLEEDING 11 0.0008
297 RENAL FAILURE ACUTE 34 0.0008
298 SPINAL OSTEOARTHRITIS 7 0.0008
299 HEART RATE IRREGULAR 18 0.0008
300 HOT FLUSH 60 0.0008
301 HEAD DISCOMFORT 14 0.0008
302 POOR QUALITY SLEEP 17 0.0008
303 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
304 THYROID DISORDER 12 0.0008
305 OSTEOARTHRITIS 33 0.0008
306 CARDIAC FLUTTER 5 0.0008
307 DELUSION 12 0.0008
308 PELVIC FRACTURE 6 0.0008
309 PERIORBITAL OEDEMA 4 0.0008
310 VENTRICULAR EXTRASYSTOLES 8 0.0008
311 PHARMACEUTICAL PRODUCT COMPLAINT 20 0.0008
312 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
313 SINUS DISORDER 15 0.0008
314 BLOOD ALBUMIN DECREASED 6 0.0008
315 RENAL CYST 6 0.0008
316 TRICUSPID VALVE INCOMPETENCE 6 0.0008
317 SOPOR 10 0.0008
318 OSTEOPOROSIS 31 0.0008
319 HYPERLIPIDAEMIA 9 0.0008
320 DEMENTIA 21 0.0008
321 WRIST FRACTURE 9 0.0008
322 PRODUCT AVAILABILITY ISSUE 17 0.0007
323 LACTIC ACIDOSIS 24 0.0007
324 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
325 BALANCE DISORDER 64 0.0007
326 SKIN DISCOLOURATION 34 0.0007
327 RASH PRURITIC 40 0.0007
328 PRODUCT LABEL ISSUE 5 0.0007
329 PULMONARY THROMBOSIS 8 0.0007
330 IMPAIRED GASTRIC EMPTYING 10 0.0007
331 EXPOSURE VIA SKIN CONTACT 19 0.0007
332 HYPERSOMNIA 21 0.0007
333 OESOPHAGITIS 8 0.0007
334 PRODUCT SUBSTITUTION ISSUE 42 0.0007
335 THERAPY INTERRUPTED 52 0.0007
336 PHOTOSENSITIVITY REACTION 12 0.0007
337 ECONOMIC PROBLEM 11 0.0007
338 BLOOD COUNT ABNORMAL 11 0.0007
339 TOOTH EXTRACTION 9 0.0007
340 BLOOD PRESSURE DECREASED 48 0.0007
341 GASTRIC ULCER HAEMORRHAGE 4 0.0007
342 MASS 10 0.0007
343 BONE DISORDER 13 0.0007
344 ACCIDENTAL OVERDOSE 26 0.0007
345 HYPONATRAEMIA 40 0.0007
346 MITRAL VALVE INCOMPETENCE 8 0.0007
347 BASAL CELL CARCINOMA 11 0.0007
348 IMPAIRED DRIVING ABILITY 8 0.0007
349 PRESCRIBED UNDERDOSE 14 0.0007
350 SYNCOPE 70 0.0007
351 ATRIAL FIBRILLATION 68 0.0007
352 HEAD INJURY 22 0.0007
353 HIATUS HERNIA 9 0.0007
354 HYPOKALAEMIA 32 0.0007
355 PLATELET COUNT INCREASED 9 0.0007
356 HALLUCINATION 52 0.0007
357 DEAFNESS 18 0.0007
358 SUBARACHNOID HAEMORRHAGE 7 0.0007
359 DEVICE USE ISSUE 12 0.0007
360 CONSTIPATION 149 0.0007
361 TOOTH INFECTION 9 0.0007
362 DYSURIA 25 0.0007
363 DECREASED INTEREST 4 0.0007
364 HYPERBILIRUBINAEMIA 7 0.0007
365 POLLAKIURIA 28 0.0007
366 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
367 BLOOD PRESSURE FLUCTUATION 16 0.0007
368 HYPOGLYCAEMIA 32 0.0007
369 CORONARY ARTERY OCCLUSION 9 0.0007
370 BOWEL MOVEMENT IRREGULARITY 5 0.0007
371 DYSSTASIA 19 0.0007
372 ARTHRITIS 51 0.0006
373 MENTAL STATUS CHANGES 18 0.0006
374 PIGMENTATION DISORDER 4 0.0006
375 CONFUSIONAL STATE 104 0.0006
376 GAIT DISTURBANCE 123 0.0006
377 APNOEA 5 0.0006
378 AGEUSIA 16 0.0006
379 HAEMORRHAGIC STROKE 5 0.0006
380 ASPIRATION 7 0.0006
381 MULTIPLE ALLERGIES 5 0.0006
382 FALL 212 0.0006
383 LYMPHOPENIA 9 0.0006
384 NIGHTMARE 22 0.0006
385 BLEPHAROSPASM 4 0.0006
386 DIALYSIS 9 0.0006
387 BLOOD URINE PRESENT 12 0.0006
388 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
389 SLEEP APNOEA SYNDROME 12 0.0006
390 SNEEZING 14 0.0006
391 ROTATOR CUFF SYNDROME 8 0.0006
392 HYPERTHYROIDISM 9 0.0006
393 FRUSTRATION TOLERANCE DECREASED 5 0.0006
394 INCOHERENT 4 0.0006
395 HAEMORRHOIDS 12 0.0006
396 BACK DISORDER 10 0.0006
397 URINARY INCONTINENCE 18 0.0006
398 DYSGRAPHIA 4 0.0006
399 HYPERTENSION 128 0.0006
400 MENINGITIS 4 0.0006
401 HYPOTENSION 120 0.0006
402 OSTEOPENIA 9 0.0006
403 URINARY TRACT INFECTION 101 0.0006
404 DIABETES MELLITUS 45 0.0006
405 MOTOR DYSFUNCTION 6 0.0006
406 ABNORMAL LOSS OF WEIGHT 4 0.0006
407 ACCIDENT 7 0.0006
408 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 28 0.0006
409 LYMPHOEDEMA 4 0.0006
410 ENCEPHALITIS 4 0.0006
411 MUSCULOSKELETAL DISORDER 11 0.0006
412 DIZZINESS 288 0.0006
413 BURSITIS 7 0.0006
414 PETECHIAE 6 0.0006
415 BRAIN FOG 9 0.0006
416 BLOOD CALCIUM INCREASED 5 0.0006
417 SCRATCH 6 0.0006
418 SWELLING FACE 37 0.0006
419 COLD SWEAT 10 0.0006
420 IMMUNOSUPPRESSION 5 0.0006
421 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
422 EATING DISORDER 12 0.0006
423 PRODUCT DOSE OMISSION ISSUE 165 0.0006
424 SENSORY DISTURBANCE 9 0.0006
425 GALLBLADDER DISORDER 10 0.0006
426 FACIAL PAIN 5 0.0006
427 SUBDURAL HAEMATOMA 8 0.0006
428 NIGHT SWEATS 18 0.0006
429 DYSPNOEA EXERTIONAL 21 0.0006
430 ANAL INCONTINENCE 5 0.0006
431 SLEEP DISORDER 39 0.0006
432 MUSCLE ATROPHY 7 0.0006
433 FAECES SOFT 4 0.0005
434 END STAGE RENAL DISEASE 10 0.0005
435 CARDIAC FAILURE CONGESTIVE 44 0.0005
436 STAPHYLOCOCCAL INFECTION 18 0.0005
437 ERECTILE DYSFUNCTION 14 0.0005
438 VENTRICULAR TACHYCARDIA 9 0.0005
439 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
440 UNRESPONSIVE TO STIMULI 14 0.0005
441 TASTE DISORDER 11 0.0005
442 BURNING SENSATION 38 0.0005
443 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
444 CHRONIC KIDNEY DISEASE 41 0.0005
445 LETHARGY 31 0.0005
446 NODULE 7 0.0005
447 BLOOD CHOLESTEROL INCREASED 25 0.0005
448 THROAT IRRITATION 24 0.0005
449 HYDRONEPHROSIS 4 0.0005
450 CONDITION AGGRAVATED 162 0.0005
451 GASTRITIS 14 0.0005
452 LEUKAEMIA 5 0.0005
453 ARRHYTHMIA 25 0.0005
454 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
455 INTENTIONAL DOSE OMISSION 15 0.0005
456 DERMATITIS CONTACT 6 0.0005
457 MICTURITION URGENCY 6 0.0005
458 DECREASED APPETITE 122 0.0005
459 HAEMODYNAMIC INSTABILITY 4 0.0005
460 BLOOD PRESSURE INCREASED 80 0.0005
461 INJECTION SITE REACTION 36 0.0005
462 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
463 FATIGUE 406 0.0005
464 GASTRIC HAEMORRHAGE 6 0.0005
465 ASTHENIA 196 0.0005
466 FEAR 14 0.0005
467 MUSCULAR WEAKNESS 59 0.0005
468 FREQUENT BOWEL MOVEMENTS 14 0.0005
469 CONCUSSION 4 0.0005
470 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
471 THERAPY NON-RESPONDER 23 0.0005
472 SOMNOLENCE 103 0.0005
473 EXPIRED PRODUCT ADMINISTERED 17 0.0005
474 FUNGAL INFECTION 17 0.0005
475 RENAL TUBULAR NECROSIS 5 0.0005
476 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
477 ACUTE MYOCARDIAL INFARCTION 15 0.0005
478 LABORATORY TEST ABNORMAL 15 0.0005
479 DYSPHAGIA 48 0.0005
480 LIGAMENT SPRAIN 5 0.0005
481 BLOOD IRON DECREASED 6 0.0005
482 BACTERAEMIA 6 0.0005
483 PRODUCT PRESCRIBING ERROR 12 0.0005
484 ORAL DISCOMFORT 7 0.0005
485 BLOOD PRESSURE ABNORMAL 10 0.0005
486 GINGIVAL PAIN 4 0.0005
487 HAEMOPTYSIS 14 0.0005
488 APHONIA 7 0.0005
489 HYPOTHYROIDISM 16 0.0005
490 METABOLIC ACIDOSIS 16 0.0005
491 CARPAL TUNNEL SYNDROME 7 0.0005
492 BLOOD DISORDER 4 0.0005
493 BRAIN INJURY 5 0.0005
494 ABDOMINAL DISTENSION 52 0.0005
495 TOOTHACHE 9 0.0005
496 ABDOMINAL DISCOMFORT 83 0.0005
497 HYPOAESTHESIA 74 0.0005
498 FEEDING DISORDER 10 0.0005
499 BLOOD POTASSIUM INCREASED 8 0.0005
500 LOSS OF CONSCIOUSNESS 63 0.0005
501 SLUGGISHNESS 5 0.0005
502 ASPHYXIA 4 0.0005
503 PARALYSIS 7 0.0005
504 ABNORMAL FAECES 4 0.0005
505 CARDIOGENIC SHOCK 7 0.0005
506 HYPERCALCAEMIA 6 0.0005
507 ABASIA 12 0.0005
508 DRUG INTERACTION 77 0.0005
509 GENERALISED OEDEMA 6 0.0005
510 DYSGEUSIA 36 0.0005
511 WEIGHT DECREASED 135 0.0005
512 BACTERIAL INFECTION 9 0.0005
513 INJECTION SITE HAEMATOMA 7 0.0005
514 HYPOKINESIA 7 0.0005
515 MIDDLE INSOMNIA 9 0.0005
516 HEMIPLEGIA 4 0.0005
517 WHITE BLOOD CELL COUNT DECREASED 52 0.0005
518 URINARY RETENTION 16 0.0005
519 BLOOD GLUCOSE DECREASED 23 0.0005
520 PLATELET COUNT DECREASED 51 0.0005
521 WEIGHT FLUCTUATION 5 0.0005
522 HAEMODIALYSIS 4 0.0005
523 FLATULENCE 27 0.0005
524 PERIPHERAL SWELLING 73 0.0005
525 BRONCHITIS 35 0.0005
526 SUDDEN DEATH 5 0.0005
527 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
528 IMMUNODEFICIENCY 7 0.0005
529 BREAST PAIN 5 0.0005
530 INFUSION SITE PAIN 6 0.0005
531 MUSCULOSKELETAL DISCOMFORT 8 0.0005
532 BLOOD MAGNESIUM DECREASED 4 0.0005
533 CARDIAC MURMUR 4 0.0005
534 STOMATITIS 28 0.0005
535 NASAL CONGESTION 27 0.0005
536 OEDEMA PERIPHERAL 56 0.0005
537 MOBILITY DECREASED 33 0.0005
538 INSURANCE ISSUE 7 0.0005
539 NAIL DISORDER 4 0.0005
540 CONTUSION 44 0.0005
541 TREATMENT NONCOMPLIANCE 25 0.0005
542 ANHEDONIA 12 0.0005
543 MUSCULOSKELETAL STIFFNESS 40 0.0005
544 BEDRIDDEN 6 0.0005
545 COUGH 128 0.0005
546 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
547 ORAL CANDIDIASIS 6 0.0005
548 GROIN PAIN 4 0.0005
549 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
550 EPISTAXIS 34 0.0005
551 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
552 HERPES ZOSTER 26 0.0005
553 ADVERSE REACTION 6 0.0005
554 LIMB DISCOMFORT 14 0.0005
555 TENDONITIS 7 0.0005
556 FOOT DEFORMITY 5 0.0005
557 HYPERTENSIVE CRISIS 5 0.0004
558 CHEST DISCOMFORT 46 0.0004
559 SPINAL FRACTURE 9 0.0004
560 SINUSITIS 46 0.0004
561 THERAPY PARTIAL RESPONDER 7 0.0004
562 HAIR TEXTURE ABNORMAL 6 0.0004
563 MALNUTRITION 5 0.0004
564 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
565 AMNESIA 29 0.0004
566 SKIN INFECTION 5 0.0004
567 SINUS CONGESTION 6 0.0004
568 GASTROENTERITIS VIRAL 8 0.0004
569 INSOMNIA 118 0.0004
570 DISCOMFORT 27 0.0004
571 BODY TEMPERATURE INCREASED 9 0.0004
572 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
573 ANAEMIA 84 0.0004
574 OPTIC NEURITIS 4 0.0004
575 AKATHISIA 6 0.0004
576 OBESITY 7 0.0004
577 HYPERGLYCAEMIA 16 0.0004
578 SKIN EXFOLIATION 37 0.0004
579 WHEEZING 26 0.0004
580 DIARRHOEA 283 0.0004
581 EXOSTOSIS 4 0.0004
582 CHOLECYSTECTOMY 5 0.0004
583 PNEUMONIA BACTERIAL 4 0.0004
584 PALPITATIONS 51 0.0004
585 HIP FRACTURE 14 0.0004
586 INCREASED TENDENCY TO BRUISE 4 0.0004
587 MUSCLE TWITCHING 10 0.0004
588 DRUG INEFFECTIVE 570 0.0004
589 BLOOD POTASSIUM DECREASED 13 0.0004
590 HEPATIC STEATOSIS 8 0.0004
591 CORONARY ARTERY DISEASE 13 0.0004
592 RASH MACULAR 15 0.0004
593 HEPATIC ENCEPHALOPATHY 4 0.0004
594 HAEMOGLOBIN DECREASED 44 0.0004
595 COGNITIVE DISORDER 20 0.0004
596 PLEURAL EFFUSION 26 0.0004
597 FLANK PAIN 4 0.0004
598 SEXUAL DYSFUNCTION 5 0.0004
599 PULMONARY OEDEMA 19 0.0004
600 FEELING HOT 26 0.0004
601 ATAXIA 5 0.0004
602 CHEST PAIN 78 0.0004
603 NERVOUSNESS 22 0.0004
604 GASTRIC ULCER 8 0.0004
605 NEUROPATHY PERIPHERAL 40 0.0004
606 BRONCHOSPASM 6 0.0004
607 ECZEMA 22 0.0004
608 COAGULOPATHY 7 0.0004
609 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
610 GAIT INABILITY 14 0.0004
611 ERYTHEMA 86 0.0004
612 PNEUMONIA 135 0.0004
613 NERVOUS SYSTEM DISORDER 13 0.0004
614 LOWER LIMB FRACTURE 8 0.0004
615 PRURITUS 160 0.0004
616 DEPRESSED MOOD 22 0.0004
617 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
618 ACUTE RESPIRATORY FAILURE 8 0.0004
619 FACE OEDEMA 7 0.0004
620 ANOSMIA 6 0.0004
621 ARTHROPATHY 23 0.0004
622 FLUID RETENTION 21 0.0004
623 LIVER FUNCTION TEST ABNORMAL 12 0.0004
624 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
625 FIBROMYALGIA 10 0.0004
626 PRODUCT STORAGE ERROR 36 0.0004
627 CHOKING 8 0.0004
628 SCAR 7 0.0004
629 HEPATOMEGALY 4 0.0004
630 KNEE OPERATION 4 0.0004
631 BODY TEMPERATURE DECREASED 4 0.0004
632 SMALL INTESTINAL OBSTRUCTION 5 0.0004
633 SPINAL OPERATION 5 0.0004
634 HOSPICE CARE 4 0.0004
635 INABILITY TO AFFORD MEDICATION 4 0.0004
636 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
637 ORAL PAIN 9 0.0004
638 RASH PAPULAR 9 0.0004
639 INJECTION SITE DISCOLOURATION 5 0.0004
640 DEPRESSION 91 0.0004
641 DYSPNOEA 226 0.0004
642 DERMATITIS ALLERGIC 5 0.0004
643 DYSPEPSIA 39 0.0004
644 HYPOACUSIS 17 0.0004
645 GASTROINTESTINAL HAEMORRHAGE 33 0.0004
646 HAEMATEMESIS 10 0.0004
647 DEVICE FAILURE 6 0.0004
648 PRODUCT USE ISSUE 74 0.0004
649 BONE PAIN 23 0.0004
650 BLISTER 22 0.0004
651 BACK PAIN 91 0.0004
652 RENAL FAILURE 52 0.0004
653 VIRAL INFECTION 13 0.0004
654 NEUTROPHIL COUNT INCREASED 4 0.0004
655 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
656 JOINT SWELLING 47 0.0004
657 PERICARDIAL EFFUSION 9 0.0004
658 RIB FRACTURE 8 0.0004
659 LYMPHOMA 6 0.0004
660 RHEUMATOID ARTHRITIS 44 0.0004
661 FEMUR FRACTURE 12 0.0004
662 ALOPECIA 76 0.0004
663 OSTEOMYELITIS 7 0.0004
664 HAEMATOMA 10 0.0004
665 ACUTE MYELOID LEUKAEMIA 6 0.0004
666 RESTLESS LEGS SYNDROME 7 0.0004
667 SWELLING 36 0.0004
668 PLASMA CELL MYELOMA 15 0.0004
669 PULMONARY HYPERTENSION 8 0.0004
670 ANGINA PECTORIS 11 0.0004
671 HEADACHE 240 0.0004
672 KNEE ARTHROPLASTY 8 0.0004
673 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
674 RASH 165 0.0004
675 INCONTINENCE 4 0.0004
676 MEDICATION ERROR 21 0.0004
677 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
678 INTENTIONAL PRODUCT MISUSE 33 0.0004
679 PAIN IN EXTREMITY 111 0.0004
680 RASH ERYTHEMATOUS 18 0.0004
681 NECK PAIN 21 0.0004
682 RETCHING 8 0.0004
683 JOINT INJURY 8 0.0004
684 ASCITES 11 0.0004
685 CARDIAC DISORDER 35 0.0004
686 MENTAL IMPAIRMENT 9 0.0004
687 DECREASED ACTIVITY 4 0.0004
688 MUSCLE SPASMS 68 0.0004
689 NEURALGIA 9 0.0004
690 UNEVALUABLE EVENT 28 0.0004
691 DYSKINESIA 15 0.0004
692 FAECES DISCOLOURED 8 0.0004
693 PRODUCT QUALITY ISSUE 50 0.0004
694 BIPOLAR DISORDER 4 0.0004
695 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
696 LUNG DISORDER 18 0.0004
697 OROPHARYNGEAL PAIN 34 0.0004
698 ACUTE KIDNEY INJURY 56 0.0004
699 BLOOD GLUCOSE FLUCTUATION 4 0.0004
700 RENAL DISORDER 17 0.0004
701 HEART RATE INCREASED 36 0.0004
702 DENTAL CARIES 4 0.0004
703 DIVERTICULITIS 10 0.0004
704 LIP SWELLING 12 0.0004
705 MALAISE 158 0.0004
706 PNEUMONIA ASPIRATION 9 0.0004
707 TACHYCARDIA 32 0.0004
708 TRANSAMINASES INCREASED 8 0.0004
709 COORDINATION ABNORMAL 5 0.0004
710 COMA 17 0.0004
711 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
712 BLOOD TEST ABNORMAL 5 0.0004
713 BLOOD CALCIUM DECREASED 4 0.0004
714 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
715 DISORIENTATION 14 0.0004
716 DEHYDRATION 47 0.0004
717 CIRCULATORY COLLAPSE 6 0.0004
718 BLOOD CREATININE INCREASED 23 0.0004
719 SWOLLEN TONGUE 11 0.0004
720 SINUS TACHYCARDIA 5 0.0004
721 HYPOPHAGIA 9 0.0004
722 ANXIETY 99 0.0003
723 IMPAIRED QUALITY OF LIFE 5 0.0003
724 RESPIRATORY TRACT INFECTION 9 0.0003
725 CYSTITIS 11 0.0003
726 BLOOD GLUCOSE INCREASED 65 0.0003
727 PRODUCT USE IN UNAPPROVED INDICATION 85 0.0003
728 APATHY 5 0.0003
729 CEREBROVASCULAR ACCIDENT 58 0.0003
730 DRUG INTOLERANCE 33 0.0003
731 HYPERHIDROSIS 44 0.0003
732 ACCIDENTAL EXPOSURE TO PRODUCT 35 0.0003
733 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
734 TOOTH LOSS 7 0.0003
735 INCORRECT DOSE ADMINISTERED 77 0.0003
736 PRODUCT DOSE OMISSION 22 0.0003
737 PULMONARY MASS 5 0.0003
738 JAUNDICE 9 0.0003
739 HAEMORRHAGE INTRACRANIAL 5 0.0003
740 DRUG EFFECT DECREASED 18 0.0003
741 BLOOD BILIRUBIN INCREASED 9 0.0003
742 OEDEMA 18 0.0003
743 LOCALISED INFECTION 8 0.0003
744 DRY SKIN 44 0.0003
745 ABNORMAL BEHAVIOUR 13 0.0003
746 NO THERAPEUTIC RESPONSE 4 0.0003
747 INFLUENZA LIKE ILLNESS 27 0.0003
748 IMPAIRED WORK ABILITY 7 0.0003
749 DRUG DISPENSING ERROR 5 0.0003
750 NEPHROLITHIASIS 15 0.0003
751 NAUSEA 258 0.0003
752 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
753 ABDOMINAL PAIN UPPER 67 0.0003
754 SPEECH DISORDER 17 0.0003
755 PRURITUS GENERALISED 7 0.0003
756 FEELING COLD 9 0.0003
757 CYST 4 0.0003
758 THINKING ABNORMAL 6 0.0003
759 LUNG INFECTION 5 0.0003
760 PANCREATITIS 17 0.0003
761 HAIR COLOUR CHANGES 4 0.0003
762 MYOCARDIAL INFARCTION 56 0.0003
763 OXYGEN SATURATION DECREASED 18 0.0003
764 PSORIATIC ARTHROPATHY 13 0.0003
765 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
766 COVID-19 56 0.0003
767 VOMITING 150 0.0003
768 MELAENA 7 0.0003
769 CYANOSIS 5 0.0003
770 PAIN IN JAW 9 0.0003
771 FEELING ABNORMAL 76 0.0003
772 HYPOCALCAEMIA 6 0.0003
773 PRODUCT COMPLAINT 8 0.0003
774 CHILLS 37 0.0003
775 PNEUMOTHORAX 5 0.0003
776 TOOTH DISORDER 7 0.0003
777 RESPIRATORY TRACT CONGESTION 5 0.0003
778 NASOPHARYNGITIS 58 0.0003
779 MEMORY IMPAIRMENT 43 0.0003
780 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
781 GLOSSODYNIA 7 0.0003
782 WEIGHT INCREASED 70 0.0003
783 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
784 RHABDOMYOLYSIS 13 0.0003
785 LYMPHADENOPATHY 11 0.0003
786 THROMBOSIS 25 0.0003
787 HERNIA 6 0.0003
788 ANAPHYLACTIC SHOCK 8 0.0003
789 ERUCTATION 6 0.0003
790 SKIN ULCER 8 0.0003
791 HOSPITALISATION 47 0.0003
792 MYALGIA 52 0.0003
793 ARTHRALGIA 127 0.0003
794 SEPSIS 34 0.0003
795 IMMUNE SYSTEM DISORDER 4 0.0003
796 DERMATITIS ATOPIC 16 0.0003
797 RENAL INJURY 9 0.0003
798 CRYING 11 0.0003
799 UNDERDOSE 22 0.0003
800 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
801 UPPER LIMB FRACTURE 6 0.0003
802 JOINT RANGE OF MOTION DECREASED 4 0.0003
803 PAIN 183 0.0003
804 CELLULITIS 15 0.0003
805 RENAL IMPAIRMENT 25 0.0003
806 OFF LABEL USE 260 0.0003
807 HEMIPARESIS 5 0.0003
808 PULMONARY EMBOLISM 28 0.0003
809 LIMB INJURY 8 0.0003
810 GENERAL PHYSICAL HEALTH DETERIORATION 34 0.0003
811 DEEP VEIN THROMBOSIS 19 0.0003
812 PARAESTHESIA 46 0.0003
813 DYSARTHRIA 11 0.0003
814 EMOTIONAL DISORDER 9 0.0003
815 RESPIRATORY DISTRESS 8 0.0003
816 ABNORMAL DREAMS 8 0.0003
817 NEOPLASM PROGRESSION 10 0.0003
818 METASTASES TO LIVER 5 0.0003
819 HYPOXIA 10 0.0003
820 SKIN IRRITATION 13 0.0003
821 ABDOMINAL PAIN 66 0.0003
822 IRRITABILITY 17 0.0003
823 ILLNESS 29 0.0003
824 THERAPEUTIC RESPONSE DECREASED 17 0.0003
825 SKIN CANCER 6 0.0003
826 GOUT 5 0.0003
827 INFECTION 40 0.0003
828 CARDIOVASCULAR DISORDER 7 0.0003
829 PRODUCT DISPENSING ERROR 6 0.0003
830 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
831 CHOLELITHIASIS 9 0.0003
832 MIGRAINE 26 0.0003
833 EXTRA DOSE ADMINISTERED 11 0.0003
834 ADVERSE EVENT 25 0.0003
835 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
836 RASH MACULO-PAPULAR 6 0.0003
837 HEPATOTOXICITY 6 0.0003
838 RESPIRATORY DISORDER 8 0.0003
839 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
840 JOINT STIFFNESS 7 0.0003
841 CARDIAC ARREST 22 0.0003
842 INJECTION SITE HAEMORRHAGE 21 0.0003
843 DEATH 226 0.0003
844 DISEASE PROGRESSION 31 0.0003
845 SHOCK 6 0.0003
846 DRUG ADMINISTRATION ERROR 8 0.0003
847 PAIN OF SKIN 7 0.0003
848 MUSCULOSKELETAL CHEST PAIN 4 0.0003
849 ANKLE FRACTURE 4 0.0003
850 EJECTION FRACTION DECREASED 4 0.0003
851 PALLOR 7 0.0003
852 MOOD ALTERED 7 0.0003
853 ASTHMA 29 0.0003
854 SKIN LESION 7 0.0003
855 NEOPLASM MALIGNANT 17 0.0003
856 TREMOR 42 0.0003
857 SEPTIC SHOCK 11 0.0003
858 PRODUCTIVE COUGH 12 0.0003
859 MOOD SWINGS 8 0.0003
860 ABSCESS 4 0.0003
861 MOVEMENT DISORDER 8 0.0002
862 MUSCULOSKELETAL PAIN 13 0.0002
863 LIVER DISORDER 11 0.0002
864 PRODUCT PHYSICAL ISSUE 5 0.0002
865 DRUG EFFECT INCOMPLETE 9 0.0002
866 MUSCLE TIGHTNESS 4 0.0002
867 RESPIRATORY FAILURE 18 0.0002
868 FLUSHING 25 0.0002
869 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
870 NEUTROPHIL COUNT DECREASED 10 0.0002
871 CONVULSION 14 0.0002
872 URTICARIA 41 0.0002
873 ENCEPHALOPATHY 6 0.0002
874 IMPAIRED HEALING 8 0.0002
875 MULTIPLE FRACTURES 4 0.0002
876 INJECTION SITE WARMTH 5 0.0002
877 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
878 LEUKOPENIA 12 0.0002
879 SURGERY 14 0.0002
880 HAEMATOCHEZIA 13 0.0002
881 HEPATIC ENZYME INCREASED 16 0.0002
882 INFLUENZA 26 0.0002
883 GASTRIC DISORDER 8 0.0002
884 RECTAL HAEMORRHAGE 10 0.0002
885 INFLAMMATION 12 0.0002
886 PARANOIA 4 0.0002
887 RASH GENERALISED 6 0.0002
888 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
889 DELIRIUM 8 0.0002
890 DRUG DOSE OMISSION 38 0.0002
891 MENTAL DISORDER 10 0.0002
892 LOCAL SWELLING 4 0.0002
893 SEDATION 6 0.0002
894 NEUTROPENIA 31 0.0002
895 INJURY 16 0.0002
896 INTERSTITIAL LUNG DISEASE 11 0.0002
897 FEBRILE NEUTROPENIA 15 0.0002
898 DRUG ERUPTION 4 0.0002
899 CARDIAC FAILURE 18 0.0002
900 CEREBRAL HAEMORRHAGE 8 0.0002
901 GASTROINTESTINAL DISORDER 20 0.0002
902 PYREXIA 77 0.0002
903 LEUKOCYTOSIS 4 0.0002
904 AGITATION 16 0.0002
905 BLOOD GLUCOSE ABNORMAL 4 0.0002
906 CARDIO-RESPIRATORY ARREST 9 0.0002
907 THROMBOCYTOPENIA 24 0.0002
908 WITHDRAWAL SYNDROME 9 0.0002
909 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
910 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
911 DISEASE RECURRENCE 10 0.0002
912 SKIN DISORDER 7 0.0002
913 INCREASED APPETITE 4 0.0002
914 HAEMATURIA 7 0.0002
915 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
916 INJECTION SITE BRUISING 16 0.0002
917 ADVERSE DRUG REACTION 18 0.0002
918 AGGRESSION 10 0.0002
919 ABDOMINAL PAIN LOWER 5 0.0002
920 INJECTION SITE RASH 6 0.0002
921 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
922 BONE DENSITY DECREASED 6 0.0002
923 HAEMORRHAGE 20 0.0002
924 RESTLESSNESS 7 0.0002
925 ROAD TRAFFIC ACCIDENT 8 0.0002
926 MUCOSAL INFLAMMATION 5 0.0002
927 MOUTH ULCERATION 4 0.0002
928 DEVICE ISSUE 17 0.0002
929 EAR INFECTION 5 0.0002
930 NO ADVERSE EVENT 34 0.0002
931 IRRITABLE BOWEL SYNDROME 4 0.0002
932 THROAT TIGHTNESS 5 0.0002
933 COLITIS 7 0.0002
934 DEVICE LEAKAGE 8 0.0002
935 PSORIASIS 24 0.0002
936 PNEUMONITIS 5 0.0002
937 APPLICATION SITE PAIN 4 0.0002
938 RESPIRATORY ARREST 5 0.0002
939 INFUSION RELATED REACTION 12 0.0002
940 PANCYTOPENIA 10 0.0002
941 TYPE 2 DIABETES MELLITUS 6 0.0002
942 ACNE 13 0.0002
943 DEVICE MALFUNCTION 12 0.0002
944 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
945 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
946 DIABETIC KETOACIDOSIS 4 0.0002
947 APHASIA 5 0.0002
948 EMOTIONAL DISTRESS 20 0.0002
949 CEREBRAL INFARCTION 4 0.0002
950 ANAPHYLACTIC REACTION 9 0.0002
951 OSTEONECROSIS OF JAW 4 0.0002
952 GYNAECOMASTIA 5 0.0002
953 EXTRAPYRAMIDAL DISORDER 4 0.0002
954 BREAST CANCER 15 0.0002
955 INTESTINAL OBSTRUCTION 6 0.0002
956 ANGIOEDEMA 7 0.0002
957 INJECTION SITE PAIN 48 0.0002
958 THERAPY CESSATION 8 0.0002
959 SEIZURE 18 0.0002
960 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
961 SKIN BURNING SENSATION 11 0.0002
962 INJECTION SITE ERYTHEMA 19 0.0002
963 INJECTION SITE PRURITUS 10 0.0001
964 PROSTATE CANCER 12 0.0001
965 ILL-DEFINED DISORDER 9 0.0001
966 ANGER 5 0.0001
967 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
968 SUICIDAL IDEATION 13 0.0001
969 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
970 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
971 PANCREATIC CARCINOMA 4 0.0001
972 INJECTION SITE MASS 5 0.0001
973 HEPATIC FUNCTION ABNORMAL 5 0.0001
974 HEPATIC FAILURE 4 0.0001
975 OSTEONECROSIS 4 0.0001
976 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
977 INJECTION SITE SWELLING 9 0.0001
978 DEVICE DISLOCATION 5 0.0001
979 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
980 OVERDOSE 23 0.0001
981 DEVICE DIFFICULT TO USE 7 0.0001
982 MULTIPLE SCLEROSIS 5 0.0001
983 DISTURBANCE IN ATTENTION 5 0.0001
984 COLITIS ULCERATIVE 4 0.0001
985 TOXICITY TO VARIOUS AGENTS 14 0.0001
986 SUICIDE ATTEMPT 5 0.0001
987 DRUG WITHDRAWAL SYNDROME 7 0.0001
988 COMPLETED SUICIDE 6 0.0001
989 EXPOSURE DURING PREGNANCY 4 0.0001
990 DRUG DOSE OMISSION BY DEVICE 5 0.0001
991 DRUG DEPENDENCE 8 0.0000